A phase 2, 24-week, multicenter, randomized, parallel-group, dose-ranging study to evaluate the effect of teriparatide nasal spray on bone mineral density in postmenopausal women with low bone mineral density

Trial Profile

A phase 2, 24-week, multicenter, randomized, parallel-group, dose-ranging study to evaluate the effect of teriparatide nasal spray on bone mineral density in postmenopausal women with low bone mineral density

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 21 Mar 2008

At a glance

  • Drugs Teriparatide; Teriparatide
  • Indications Bone resorption; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Marina Biotech
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top